Sjögren-larsson syndrome: A novel mutation in a Moroccan child;Syndrome de Sjögren-Larsson en rapport avec une nouvelle mutation chez un enfant marocain

Archives de Pediatrie

Volumn 15, Issue 11, 2008, Pages 1648-1651

  Rafai, M A ^a   Boulaajaj, F Z ^a   Seito, A ^b   Suga, Y ^c   Slassi, I ^a   Fadel, H ^d  

^a IBN ROCHD UNIVERSITY HOSPITAL   (Morocco)

^b Institut Pasteur du Maroc   (Morocco)

^c Japan Development and Medical Affairs Division   (Japan)

^d Al Kortobi Hospital   (Morocco)

Author keywords

[No Author keywords available]

Indexed keywords

ALDEHYDE DEHYDROGENASE; FATTY ALDEHYDE DEHYDROGENASE; UNCLASSIFIED DRUG;

ARTICLE; CASE REPORT; EPILEPSY; GENE MUTATION; HUMAN; MENTAL DEFICIENCY; NUCLEAR MAGNETIC RESONANCE IMAGING; SCHOOL CHILD; SJOEGREN LARSSON SYNDROME; SPASTIC PARAPLEGIA;

ALDEHYDE OXIDOREDUCTASES; CHILD; FEMALE; HUMANS; MOROCCO; MUTATION; PEDIGREE;

EID: 55349101587     PISSN: 0929693X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arcped.2008.07.022     Document Type: Article

References (14)

1. Van Domburg P.H., Willemsen M.A., Rotteveel J.J., et al. Sjögren-Larsson syndrome: clinical and MRI/MRS findings in FALDH-deficient patients. Neurology 52 (1999) 1345-1352
2. Willemsen M.A., IJlst L., Steijlen P.M., et al. Clinical, biochemical and molucular genetic characteristics of 19 patients with the Sjögren-Larsson syndrome. Brain 124 (2001) 1426-1437
3. Fernández-Vozmediano J.M., Armario-Hita J.C., et al. Sjögren-Larsson syndrome: treatment with topical calcipotriol. Pediatr Dermatol 20 (2003) 179-180
4. Cubo E., and Goetz C.G. Dystonia secondary to Sjögren-Larsson syndrome. Neurology 55 (2000) 1236-1237
5. Misery L., Antoine J.C., Touraine R., et al. Syndrome de Sjögren-Larsson Deux cas de diagnostic tardif. Ann Med Interne (Paris) 153 (2002) 280-282
6. Lossos A., Khoury M., Rizzo W.B., et al. Phenotypic variability among adult siblings with Sjögren-Larsson syndrome. Arch Neurol 63 (2006) 278-280
7. Carney G., Wei S., and Rizzo W.B. Sjögren-Larsson Syndrome: seven novel mutations in the fatty aldehyde dehydrogenase gene ALDH3A2. Hum Mutat 24 (2004) 186
8. Bradling-Bennett H.A., and Liang M.G. What syndrome is this? Sjögren-Larsson syndrome. Pediatr Dermatol 22 (2005) 569-571
9. Rizzo W.B., Carney G., and Lin Z. The molecular basis of Sjögren-Larsson syndrome: mutation analysis of the fatty aldehyde dehydrogenase gene. Am J Hum Genet 65 (1999) 1547-1560
10. Rizzo W.B., Lin Z., and Carney G. Fatty aldehyde dehydrogenase: genomic structure, expression and mutation analysis in Sjögren-Larsson syndrome. Chem Biol Interact 130-132 (2001) 297-307
11. Willemsen M.A., Cruysberg J.R., Rotteveel J.J., et al. Juvenile macular dystrophy associated with deficient activity of fatty aldehyde dehydrogenase in Sjögren-Larsson syndrome. Am J Ophthalmol 130 (2000) 782-789
12. Haddad F.S., Lacour M., Harper J.I., et al. The orthopaedic presentation and management of Sjögren-Larsson syndrome. J Pediatr Orthop 19 (1999) 617-619
13. Rizzo W.B. Sjögren-Larsson syndrome: explaining the skin-brain connection. Neurology 52 (1999) 1307-1308
14. Auada M.P., Puzzi M.B., Cintra M.L., et al. Sjögren-Larsson Syndrome in brazil is caused by common C.1108-1G→C Splice-site mutation in the ALDH3A2 gene. Br J Dermatol 154 (2006) 770-773